Active ingredientProcarbazine HClCat. No. P-P197-001CAS 366-70-1Family · Pharmaceutical analytical standards
Procarbazine
An alkylating chemotherapy agent of the methylhydrazine family, approved in the United States in 1969: it is part of MOPP, the first combination chemotherapy regimen for Hodgkin lymphoma, and is also used for some brain tumours. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It was originally synthesised as a monoamine oxidase inhibitor, like some antidepressants: only later was its anticancer activity discovered, and it still keeps a weak MAOI effect.
Go to the active ingredient →Active ingredientProcarbazine HClCat. No. P-P197-001CAS 366-70-1
Isotopically labelledProcarbazine-d3Cat. No. P-P197-002CAS 98600-74-9
NitrosamineN-Nitroso ProcarbazineCat. No. P-P197-003
Impurity4-Formyl-N-isopropylbenzamideCat. No. P-P197-004CAS 13255-50-0
ImpurityAzoprocarbazineCat. No. P-P197-005CAS 2235-59-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.